Tags Posts tagged with "cannabis stock"

cannabis stock

marijuana stocks

A Revolutionary Cannabis Investment?

Some of the greatest investment minds in the world say, “You invest in management.” And since the birth of MarijuanaStocks.com, few management personnel have shined brighter than Cannabis Wheaton Income Corp. CEO Chuck Rifici. Mr. Rifici has accomplished with Cannabis Wheaton something that no other cannabis industry CEO has. The business model he has implemented is something that we feel every marijuana investor MUST know about. Cannabis Wheaton (KWFLF)(CBW.V) provides a very unique opportunity for marijuana investors by greatly reducing risk while still maintaining tremendous upside potential.

But before we explain the Cannabis Wheaton business model and why we feel EVERY investor should know about it, let’s first take a look at Chuck Rifici. Because as we said earlier, “you invest in management.” And there may not be a more recognizable managerial figure who has done more for the marijuana industry than Mr. Rifici.

Invest in Management

Chuck Rifici is responsible for co-founding and taking public the largest full-scale producer of government-sanctioned marijuana as its CEO in April 2014; a company by the name of Tweed Inc. whose name later changed to Canopy Growth Corp. (TWMJF)(WEED.TO). To this day, Canopy Growth remains the largest public cannabis company with a staggering market cap of approximately $1Billion. In 2016, WEED hit $17.86 approximately 550% higher than the IPO price. It is widely agreed to be the most successful marijuana company to go public and is seen as the benchmark and leader of the industry.

Take a look at how WEED stock has performed over the last 2 years:

marijuana stocks

When considering an investment in any company, it’s important to look at the management team. Who is leading the ship? Is this their first rodeo? Or have they already proven successful in bringing a company to market that has built shareholder value? Well, Chuck Rifici’s track record with co-founding Tweed speaks for itself and gives Cannabis Wheaton shareholders confidence that they have a marijuana industry trailblazer leading their ship.

But Rifici’s resume is filled with much more than just Tweed. In 2011, Rifici was appointed CFO of the Liberal Party of Canada by interim party leader Bob Rae. In 2014, Rifici was also named to the Top Forty under 40 by Ottawa Business Journal, named Alumnus of the Year by the University of Ottawa Faculty of Engineering, and received the Exceptional New Business Award by the Ottawa Chamber of Commerce.

Rifici also sat on the Board of marijuana starlets Supreme Pharmaceuticals (SPRWF) (SL.CN), Aurora Cannabis (ACBFF) (ACB.V), and CannaRoyalty (CNNRF) (CRZ.V). These board positions helped Rifici keep his ear to the ground, expand his network, and gain insight to the marijuana industry in both Canada and the U.S. He actually just resigned from his Supreme Pharma and Aurora Cannabis Board seats because of a slight conflict of interest but mostly to focus all of his time and energy towards building Cannabis Wheaton into a revolutionary cannabis company.

Cannabis Wheaton’s Streaming Model—Revolutionizing Cannabis Investment

Cannabis Wheaton is the first company to bring a streaming business model to the marijuana industry. This unique model can greatly reduce risk for investors while maintaining tremendous upside potential from a booming industry. Streaming business models are normally found in the mining industry and refer to when a company strikes a deal with a miner to purchase all or part of its future metal production in exchange for upfront cash. Perhaps the most notable example is silver giant Silver Wheaton (NYSE: SLW). This works well because mining is a very cash intensive business and requires a lot of upfront capital. And the cannabis industry is about to undergo a massive expansion that will be an serious capital burden on current marijuana producers.

Rifici has said that the marijuana industry must increase total production by 10 times the current rate in order to keep pace with the increased demand for marijuana once the drug is legalized for recreational use. Producers are barely keeping up with cannabis demand from just medical marijuana users, never mind when legal recreational use goes into effect.

Currently, there is only 1.4 million square feet of licensed medical marijuana production facilities in Canada. According to Rifici, 14 million square feet is needed to satisfy the upcoming demand. Such a massive expansion is a major financial burden and carries great risk for companies trying to expand so much so quickly. And that is where the opportunity lies for Cannabis Wheaton.

“We’re going to see tremendous growth in the industry…There have been a lot of announced expansions that fill maybe a third of that gap. But there’s still 6 or 7 million square feet that needs to be built out,” said the Rifici.

Under the streaming model, Cannabis Wheaton will provide marijuana producers with the necessary capital to expand their operations in exchange for a minority equity stake in the company and a portion of their future production at an agreed upon discounted price. The company will also provide their partners with guidance and expertise on facility construction, cultivation, and the licensing process. Rifici has brought to Wheaton several of the early key members of Tweed including the top cannabis legal team in Canada that has helped half a dozen Licensed Producers (LPs) obtain their licenses.

Cannabis Wheaton has already signed 16 streaming deals with 14 partners across 6 different provinces of Canada. Their partners’ credentials include:

  • 2 sales licenses.
  • 3 cultivation licenses.
  • 4 affirmation letters.
  • 5 advanced pre-affirmation stage applicants.

Through these agreements, Cannabis Wheaton already has access to 1.3 million square feet of cultivation by 2019, 30,000 registered medical marijuana patients, and nearly 40 medical cannabis clinics.

One agreement we feel worth mentioning specifically is the company’s deal with Broken Coast Cannabis Ltd., a British Columbia based medical cannabis producer that has established itself as a top provider of high grade cannabis products. Broken Coast’s clean tech production methods and systems deliver consistent premium cannabis. The company was also recently awarded one of the few 18-month Access to Cannabis for Medical Purposes Regulation (ACMPR) licenses, which is a testament to its compliance record.

Broken Coast and its entities will utilize the experience and capital of Cannabis Wheaton to accelerate expansion and scale production in a short period of time. Under the terms of the agreement between the companies, Broken Coast will source a proposed site to complement their current site. The parties expect the new location to accommodate at least 100,000 square foot state-of-the-art cannabis cultivation facility.

Broken Coast will operate the new facility in accordance with its industry best practices and the two companies will share the proceeds with Cannabis Wheaton receiving 49% of the product output.

5 Reasons to Consider Cannabis Wheaton

  1. Licensed Producer Diversification- Because the company is working with such a wide range of cannabis cultivation companies and receiving both an equity stake in those companies and a percentage of the end product, shareholder risk is spread out amongst several companies rather than just one.
  2. Exposure to Tremendous Upside- Usually, reducing risk results in reduced potential reward, too. But not in this case. Even with the reduced risk, shareholders are exposed to the explosive industry expansion that Rifici explained as being a 10x expansion. Current cannabis revenue numbers in Canada will pale in comparison to what we see once legal recreational use goes in effect. Cannabis Wheaton will hold an equity stake in many producers as well as owning portions of the end product at a discounted price.
  3. Geographic Diversification- Cannabis Wheaton has signed agreements with partners across 6 different provinces in Canada. This brings exposure to several different markets and acts almost as a loophole for the company to take advantage of a few question marks the industry has regarding distribution.
  4. Proven Business Model- The streaming business model has already been proven successful for some of the largest metal miners in the world. Silver Wheaton, a streaming company with a market cap of approximately $10Billion, went to this model because they generally have a bullish outlook on the price of silver. So, it makes sense for them to fund a miner’s drilling operations and expansion to purchase the future metal output at a steep discount. Similarly, Rifici and Cannabis Wheaton have a bullish outlook on the production rate and revenue numbers for marijuana in Canada expecting a 10x expansion of the industry. So, it makes sense to help fund the expansion in return for equity ownership and a portion of the end product.
  5. Successful Management- The team behind Cannabis Wheaton has already taken the largest producer of government-sanctioned marijuana public. And it was and remains the most successful IPO in the cannabis space and true leader of the industry. 

Conclusion

Ever since Rifici co-founded Tweed and brought the cannabis juggernaut public in 2014, investors wondered what his next project would be. Rifici said he is proud of what he built with Tweed but was ready to put the past behind him.

“I’m essentially moving on to what I think are far better opportunities in the space,” said the Cannabis Wheaton CEO.

It’s hard to imagine what opportunities could be more successful than a $1Billion market cap, top marijuana producing, cannabis leader that gained 550% from its IPO. But if anyone knows an opportunity in the marijuana space when they see one it’s Chuck Rifici.

Licensed Producers are already having trouble keeping up with demand from about only 130,000 registered medical marijuana patients. When legal recreational use goes into effect, demand is going to skyrocket. The current 1.4 million square feet of cultivation facility space simply isn’t going to cut it. Not even close. The entire industry is racing to undergo a massive expansion that will see cultivation space increase by about 10 times. That type of expansion is extremely costly and carries great risk for individual producers.

However, with their streaming business model, Cannabis Wheaton is de-risking the expansion while still giving investors exposure to the booming industry growth. With 16 agreements already inked with 14 different partners across 6 different provinces, Cannabis Wheaton could very well be revolutionizing the way investors capitalize on the cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 9224

When We Connect the Dots, You Profit 
Connect the Dots Articles Have Returned 9,932% for Our Readers 

Over the last couple years, as the marijuana industry has taken flight, it has been our mission to help our readers make money from cannabis. Every once in a while we publish a “Connect the Dots” article highlighting a company or group of companies that we believe have tremendous near-term upside potential. By identifying these companies and providing insight and research otherwise unavailable to the mainstream investor, we have been able to help our readers gain as much as 9,932% in about two and a half years. That is the combined gain percentage that all of our Connect the Dots companies experienced in the weeks and months after we published an article. Let’s take a look at some of our biggest gainers:

*CannaGrow Holdings (CGRW); previously BizAuctions (BZCN) click here for article
Connect the Dots published on 10/8/14 at $0.053
CGRW hit $3.45 on 10/18/16
6,409% gain 

*Rocky Mountain High (RMHB); previously Totally Hemp Crazy (THCZ) click here for article
Connect the Dots published on 12/18/14 at $0.0115
THCZ hit $0.32 on 4/1/15
2,683% gain

*Future Farm Technologies (FFRMF); previously Arcturus Growthstar Technologies (AGSTF) click here for article
Connect the Dots published on 10/4/16 at $0.137
FFRMF hit $0.541 on 2/22/17
295% gain

*Vitality Biopharma (VBIO) click here for article
Connect the Dots published on 12/6/16 at $1.01
VBIO hit $4.24 on 12/27/16
320% gain

These are just a few of our previous Connect the Dots highlights. And as you can see, the track record speaks for itself. It is our goal to literally connect the dots for our readers to help identify opportunity in this budding industry. And thus far we have done more than just identify opportunity; we have helped some earn a small fortune.

Now we know it’s impossible to have captured all of the 9,932% gains. So let’s say you were able to capture just half. A $5,000 investment would be worth $248,300. Again, that’s if you only captured half of the total gains.

The marijuana industry is at a very interesting stage of its development right now. Even with nearly 10,000% gains in the books, we still feel that we’ve only seen the tip of the iceberg. And it’s one mighty iceberg. We hope that you are happy with the content we provide and continue to read our articles on a daily basis. Because you never know when the next cannabis opportunity will bud.


Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1102

Ubiquitech CEO gives overview on 2017 progress for its division HempLife Today along with expectations for the remainder of 2017

DENVER, CO–(Marketwired – May 4, 2017) – Ubiquitech Software Corp. ( OTC PINK : UBQU ), CEO and the management of (UBQU) and Hemplife Today™ want all shareholders, and the general public, to have an update and overview on the exciting progress to date in 2017. The company also includes goals for the remainder of the year.

CEO James Ballas said, “This is our opportunity to update our shareholders on all of the important aspects of the Company that keeps us growing and profitable. It also keeps the shareholders aware of many of our plans for the rest of the year.”

Name change: The Company is 100% committed to the new name and symbol change that will help to better position the Company in the emerging Nutraceutical space. We are entering the final phase of this process and anxiously await the positive impact that we believe this name change will provide to the business and to shareholders.

New Website: The Company has commissioned an internationally known Web Design Company to do a complete makeover of the HempLifeToday.com Website, and progress on the new Website began last month. The new Website will have expanded pages on important topics and will have a completely fresh and improved look and design. In addition, there will be a new HempLifeToday™ logo as well as a detailed “Investors” page. The Company expects to unveil the new Website in June.

CBD Oil Sourcing, third party testing and expansion: The Company, through its grow operations, continues to utilize only purpose grown USA Hemp for all of its CannazALL™ products, and all Hemp used in CannazALL™ products is grown under a state agriculture program that is 2014 Farm Bill compliant, section 7606.

In addition, the Company utilizes third party testing for potency, purity, and consistency, and expanded its available growing capabilities in order to meet demand now, and in the future.

Products: The Company and its customers are very pleased with the quality and consistency of the CannazALL™ CBD products derived from Hemp currently offered, and all CannazALL™ products utilize the NanoTech™ Infusion Process where up to 200% more Terpenes and plant Sterols are infused into the products. These products are; 250mg and 500mg Peppermint Tinctures, 300mg and 800mg Concentrated Oils, 25mg CBD GelCaps, CBD Skin Salve, Vape Oil, as well as two products still being refined; CBD Powder and Dab. The company will continue to spend on research and development to insure continued new and innovative products for our customers.

Pricing: The Company lowered its pricing three times in the last two years and the current pricing will remain. However, there are many ways that customers can save and this brings CannazALL™ products to a most competitive level for the quality USA grown products featured. Currently, the Company offers three ways that customers can save. They are:

Rebates: Where customers receive a $25 rebate for every $250 spent. Customers can access their Rebate by simply logging on to HLTRebates.com

Referrals: Where customers earn free CannazALL™ CBD products by referring others. Customers can access their Rebate by simply logging on to HLTReferrals.com

Discount Codes: Where customers can receive regular weekly discounts of 10% – 30%

Rapid Ship Processing: The Company instituted its rapid Ship Processing System in January which sees orders shipped within 24 hours via USPS Priority Mail.

24 hour Interactive Customer Support line: The Company developed a state-of-the-art 24 hour Customer Support line that allows customers access to information on CBD, CannazALL™ products, pricing, dosing and more, as well as the ability to speak to a live CBD specialist who can answer questions and take an order.

Social Media: The Company has expanded its Social Media presence including, Facebook, twitter and Instagram, and this aspect of the Company is growing monthly.

Customer base: The Company added to both its active customer base and subscriber list, with over 45,000 customers combined. This growth exceeded Company projections by over 20%.

Free-Trial offer: The Company instituted a very successful Free-Trial offer of its CannazALL™ CBD GelCaps in the month of April, and requests for this free offer were overwhelming with over 6,000 requests made within the first 72 hours. The traffic to the HempLifeToday.com Website was so heavy that the Site experienced three major crashes in this period and the Company was forced to make an early move to a new and larger server that could handle the massive traffic. Because of this overwhelming response the Company is currently building out a platform to make this free offer a permanent part of its marketing plan and this platform will be completed by the week of May 8th. Initial goals are to giveaway 1,000 free trial packs of six (6) CBD GelCaps per week, and the Company expects this to grow to 5,000 per week within the next 90 days. The Company shows a 25% purchase rate based on the free trial offer and this will add significantly to Company revenue.

Direct Mail and email Campaigns: The Company continues it’s successful Direct Mail Campaigns targeted to its in-house database. These campaigns feature specific product specials as well as Discounts, and go deeper into the customer base than the weekly email campaigns that are very successful as well.

Marketing: The Company continues to grow its previously announced, and profitable, marketing and advertising platforms that are growing the Company at a sustainable rate and will keep shareholders updated on additions, etc, as they develop.

Sales: The Company continues consistent quarter over quarter growth and posted strong first quarter revenue and earnings gains announced in press on April 20th. The Company wants shareholders to note that these gains were a direct result of the positive steps the Company is taking, and that the Company will continue expanding these successful strategies.

CEO James Ballas added, “We used all of 2016 to set the Company up for more rapid growth and this is what we are achieving. As we continue on this successful path we expect to exceed our projections this year and do nothing but concentrate on growth into 2018 and beyond.”

Operations Manager Luke Dreyer said, “From a technical standpoint we are in a great position to grow at a greater rate than ever before and this is because of all of the components we now have in place. From seed to product, sales, delivery and customer support, we have everything in place that a successful Company needs to double and triple its sales as we continue. This is a very exciting business and we are thrilled at what the CannazALL™ brand has become.”

The Company looks forward to keeping shareholders aware of all important aspects of the Company and plans to update shareholders through consistent press.

About HempLife Today™
Hemp Life Today™ was created by a group of highly motivated, skilled and health minded people. Who have learned that Hemp, and Hemp related products, can be a great source of increased health, vitality, and overall well being in our lives. We also believe that high grade CBD (Canabidiol), could very well be the miracle supplement the world has been waiting for as more and more people discover the health benefits of this remarkable extract. hempLife Today™ offers its quality CBD products @ www.HempLifeToday.com

About Ubiquitech

Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday™.

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It’s popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com

This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the date of this release.

    0 3812
    marijuana stocks

    VBIO has now gained 42% since we re-initiated coverage on the company on April 20th at $1.93. On May 3rd, VBIO rocketed out of the gate hitting a high of $2.74 after announcing the addition of key clinical advisors in gastroenterology. This comes just days after we sent an email to subscribers saying to look for a break above resistance as momentum could pick up soon. And our timing was perfect.

    This is the second time we initiated coverage on this company and the results are beginning to look a lot like the first time. Our initial coverage began back on December 6, 2016, at $1.01. Within less than 1 month, VBIO exploded 320%. Now, here we are less than two weeks into our second round of coverage and VBIO has already gained 42%.

    cannabis stock

    Check out the experience of the advisors the company just added:

    Vitality Biopharma Adds Key Clinical Advisors in Gastroenterology

    Vitality Biopharma announced Dr. Douglas A. Drossman and Dr. Mark Gerich as clinical advisors with expertise in gastroenterology and treatment of digestive disorders.

    Douglas A. Drossman, M.D., is a founder and now President of the Rome Foundation, an independent nonprofit research organization dedicated to improving the lives of people with functional GI disorders. Dr. Drossman is an Emeritus Professor of Medicine and Psychiatry at the University of North Carolina (UNC) School of Medicine. He is a recognized expert in the diagnosis and treatment of narcotic bowel syndrome, a severe form of opiate-induced abdominal pain, having authored seminal publications describing this condition. Dr. Drossman established a program of research in functional GI disorders at UNC more than 25 years ago and has published more than 500 books, scientific articles, and abstracts. He received his MD from Albert Einstein College of Medicine in 1970 and completed medical residencies at the University of North Carolina School of Medicine and the New York University-Bellevue Medical Center.

    Mark Gerich, M.D., currently serves as the Clinical Director of the University of Colorado Crohn’s & Colitis Center and conducts clinical and translational research focused on the pathogenesis and treatment of inflammatory bowel disease (IBD). He received his undergraduate degree from Cornell University and a dual MD/MBA degree from McGill University in Montreal, Quebec, Canada. Dr. Gerich received his internal medicine training at the University of California Davis Medical Center and completed his fellowship in gastroenterology and hepatology at the University of Colorado in 2011. After completing an advanced IBD fellowship at Cedars-Sinai Medical Center in Los Angeles, Dr. Gerich joined the faculty in the Division of Gastroenterology and Hepatology at the University of Colorado.

    These key additions add to an already attractive story unfolding with Vitality Biopharma. And we were some of the first ones to identify the opportunity. Our timing continues to be spot on so stay tuned for further updates regarding VBIO.

     


     

    Disclaimer: Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information

      0 2547

      Wow, another record volume day for Vinergy Resources (VNNYF). This action has definitely got our attention. We re-initiated coverage of this company on May 1, 2017, at $0.33 and in just three days we have already seen a record setting volume day TWICE and a steady 27% climb.

      cannabis stock VNNYF

      Today, May 3rd, VNNYF made a new 3-day high of $0.42 on record volume. We are getting a lot of messages from subscribers asking about what the acquisition of MJ Biopharma could mean for Vinergy and its shareholders. To get up to speed, read this article to see what investors should know about the pending acquisition of MJ Biopharma:

      The Significance of the MJ Biopharma Acquisition – What Investors Should Know

      As most of you already know, trading of Vinergy on the Canadian stock exchange under symbol VIN.CN has been halted pending a fundamental change in the company. It is our opinion and assumption that this ‘fundamental change’ could be the completion of the MJ Biopharma acquisition that the company mentioned months ago. We cannot be certain of this, but there is a lot of buzz circulating right now about this potential acquisition and the recent trading activity on the U.S. side in VNNYF. If you haven’t done so already, familiarize yourself with Vinergy Resources (VNNYF) and MJ Biopharma. Because if this acquisition is completed, the most informed investors will be in the best position.

       


       

       

      Disclaimer: Pursuant to an agreement between MAPH and a non-affiliate third party, we were hired for a period of 1 month from 5/1/2017 – 6/1/2017 to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market.We may buy or sell additional shares of (VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

       

      0 2169
      marijuana

      Another strong day in the books for Vinergy Resources (VNNYF) as the stock gained 11% today, May 2, 2017. With this type of action, everyone should be starting to take notice and paying attention. Volume was again at record levels which could be signaling that investors are starting to act ahead of the possible completed acquisition of MJ Biopharma. VNNYF has now gained 23% since we re-initiated coverage on the company just two days ago.

      As we pointed out earlier, trading for Vinergy Resources on the Canadian exchange under symbol VIN.CN has been halted pending a fundamental change in the company. Through corporate announcements and pure logic it is our assumption that the fundamental change is the completion of the MJ Biopharma acquisition. The hype and speculation that helped skyrocket Vinergy’s stock nearly 200% earlier this year (when we first initiated coverage on the company), could finally be coming to fruition. The hype that drove investors wild just a few months ago could soon be reality.

      While trading of Vinergy in Canada under VIN.CN is halted, trading on the U.S. exchange through symbol VNNYF is picking up in a huge way. We have seen record volume days this week and a consistent, steady climb in share price. It would appear that momentum is in our favor as speculation once again starts to swirl around chat rooms and message boards about what the MJ Biopharma acquisition could mean for VNNYF and its shareholders. For more on why it’s significant and what investors should know about the acquisition, click here.

      What a Scientific Advisory Board Addition Means for the Company’s Cannabis Initiative

      Vinergy recently made a jaw dropping addition to their Scientific Advisory Board that seems to be in line with an MJ Biopharma acquisition. The company recently added John Simon, a senior member of the American Society for Quality, a certified quality auditor and registered quality assurance professional. Mr. Simon has been directly involved with FDA and Health Canada audits of drug manufacturers, testing facilities, and clinical sites.

      Simon assists companies with both site and product licenses. He has helped several companies obtain, renew, and maintain in good standing Drug Establishment Licenses, Medical Device Establishment Licenses, Natural and Non-prescription Site Licenses, and Licenses to Cultivate and Distribute under the Marihuana for medical Purposes Regulations (MMPR which is now under the ACMPR).

      He has extensive experience when it comes to product submissions to both the FDA and Health Canada. Simon will play a key role in driving the company’s cannabis product and technology initiatives. His work could be critical to MJ Biopharma’s long-term strategy of conducting studies out of a state-of-the-art lab focused on identifying specific cannabinoid isolates for targeted therapeutic purposes.

      John Simon could be VNNYF’s bridge to the FDA and Health Canada hopefully ensuring a smooth approval and licensing process for the company. We could be speculating here a bit but it certainly seems like the addition of John Simon was carefully calculated by management and could return tremendous value for the company.

       Disclaimer: Pursuant to an agreement between MAPH and a non-affiliate third party, we were hired for a period of 1 month from 5/1/2017 – 6/1/2017 to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market.We may buy or sell additional shares of (VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

      0 1907
      marijuana

      $UBQU Premieres New 24 Hour Interactive Customer Support Phone System

       

      Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its operating subsidiary HempLife Today™, is announcing the development and implementation of its new IVR (Interactive Voice Response), 24 hour toll-free customer support phone system, developed to improve customer support, customer satisfaction, and increase sales volume.

      This new IVR system was developed using one of the most technologically advanced software applications in the industry, and will help the Company to better serve its daily increase of customers for its growing line of CannazALL™ CBD products derived from Hemp, by offering an easier way to learn more about the Company, the products, and to better speak to a specialist who can assist in taking an order.


      Click Here Now To Read Full PR


      7 Cannabis Company Developments to Highlight

      This week was a busy week for cannabis stocks and this is important as it follows a couple rough weeks of trading. Some of the important develops we think investors should take note of, include…[continue reading]


      Click Here Now To Read Full Article


      #ICYMI: Will This Marijuana Stock See a Record Setting Year in 2017?

      Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

      One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU). Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year. What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.


      Click Here Now To Read Full Article


       

      Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

      0 1601

      Rocky Mountain High Brands Discusses Series A Preferred Restructuring

      DALLAS, March 17, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water, offered an explanation of its recent move to increase the voting and conversion rights of its Series A Preferred Stock.

      Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., said, “With the recent acquisition by LSW Holdings, LLC of the Company’s Series A Preferred Stock, we have reviewed our equity structure and are making changes to it to both protect the Company and to provide for its future growth. The Series A Preferred Stock is the Control Block for the Company. It has special rights associated with it and is not designed or intended to be converted to Common Stock. Changes to its voting rights and conversion rights were made to ensure that LSW Holdings maintains control of the Company in the event of corporate actions such as a merger/acquisition or hostile takeover.”

      Welch continued, “Lily Li and other principals and representatives of LSW Holdings were in Dallas this week to meet our Rocky Mountain High team and discuss future plans for the Company. With the opportunities that LSW Holdings will bring into the Company, we need to protect the Company and its shareholders from a hostile takeover or any other uninvited action not in the best interest of the Company or its shareholders. The restructuring of the Series A Preferred Stock voting and conversion rights are a part of that plan.”

      About Rocky Mountain High Brands:

      ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

      For interested investors, our stock symbol is RMHB.

      For ordering information please visit: LiveRockyMountainHigh.com

      For corporate information please visit: RockyMountainHighBrands.com

      For information on our high alkaline water visit: EagleSpiritWater.com

      For Rocky Mountain High Distribution Contact:

      Chuck Smith (972) 955-0964
      chuck@rockymountainhighbrands.com

      Visit us on Facebook: https://www.facebook.com/rockymountainhighbrands?fref=nf

      Visit us on Twitter:
      #GetYourHempOn

      Visit us at Investors Hangout: http://investorshangout.com/Rocky-Mountain-High-Brands-Inc-RMHB-69150/

      Investors Hangout is the only authorized Investors blog page for Rocky Mountain High Brands, Inc.

      Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

      1 12371

      How Have Marijuana Stocks Performed Post Trump?

      Here we are, the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.

      As we’ve said in the past, a lot of marijuana stocks are event driven. Going all the way back to 2014 and during the years to follow, catalysts in the cannabis market can be tied to actual events in many cases. For this most recent jump in marijuana stock prices, we see that an election year and a not so conservative President may be the event to thank for this.

      In this article we’ll briefly explore some of the most active and most bullish marijuana stocks in the market to give a clear example of “where we’ve been” and what we might be able to look forward to as to “where we’re going”.

      OWC Pharmaceutical Research Corp. (OWCP) 3,512%

      This company has been building steam since October and just recently went into overdrive to all time highs. Through its subsidiary, One World Cannabis, the Israeli-based company develops cannabinoid-based therapies that target different medical conditions. This was another cannabis biotech company that saw the impact of Trump coming into office instead of Clinton (who was very bearish on biotech).

      In late October just before the elections, OWCP saw its first noticeable move from under $0.03 and initially ran to highs of $0.215. Following the consolidation period heading into the end of the year (as most marijuana stocks saw), January opened the door for this stock to run as high as $0.95

      OWCP_Marijuana_Stocks

       

      Rocky Mountain High Brands (RMHB)
      271%

      We’ve reported on this company and followed it for a few years. Even before when it was “Totally Hemp Crazy (THCZ)” this stock saw one of the biggest breakouts that we’ve every witnessed. It went from sub penny to highs of 0.32 within weeks. Now it appears that chart has demonstrated a similar Trump Bump that many of the other marijuana stocks have also seen.

      In early October, volume began to build, RMHB ran from $0.031 to highs of $0.07. After consolidating back to 0.03-0.04, RMHB has now seen its 2017 rally trigger and has now managed to run past $0.11. Rocky Mountain is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots, as well as a Relaxation Brownie.

      Marijuana Stock

      Ubiquitech Software Corp. (UBQU)
      304%

      UBQU follows a similar trend where even though it hasn’t broken above its year end highs, the stock has seen a reversal that started at the beginning of 2017. A lot of questions were raised regarding a previously announced name change and recently the company gave clear guidance on this for 2017 that has brought attention back to the stock from market bulls. Its final name change will be Endo BioSciences Inc., and HempLife Today™ will continue to be the main subsidiary of the company.

      HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid.

      marijuana stocks

      mCig, Inc. (MCIG)
      1,265%

      A company that we’ve kept up with for the better part of the last year, MCIG became another clear example of what marijuana stocks have started to look like after Donald Trump was elected President. The company has been making many key strides over the last few months including posting some of its best numbers in history.

      This includes MCIG currently holding over $10 million in order/contract backlog (as of their last PR in December). In similar fashion to OWCP, shares of MCIG saw a bump in late October when the stock moved from under $0.04 to as high as $0.218. After consolidating in early December, MCIG manage to rally strong heading into the end of the year and recently hit highs of $0.505.

      cannabis stocks

      Axim Biotechnologies, Inc. (AXIM)
      3,941%

      Another company that we’ve been following very closely, this has been one of the biggest runners of the year amid heavy volatility. Another cannabis biotech, the company focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. MJNA is also an investor in AXIM.

      In late October the stock was trading just under $0.50 moved to a high of $10 before consolidating to levels between $7.50-$8. Wouldn’t you know it, heading into the beginning of 2017 the stock broke the sideways trend and moved to highs of $19.80.

      cannabis stock

      Vitality Biopharma (VBIO)
      361%

      A company that many of us are familiar with, this cannabis biotech had a smaller run a few weeks before we started picking up coverage. In early October, the stock moved up from around $0.92 to highs of $1.84. After pulling back to lows in December, we began looking at this company at $0.98 and watched as it ran to highs of $4.24. The company is a cannabis biotech focusing on treating disease through its prodrug utilizing cannabinoids for the treatment of serious neurological and inflammatory disorders.

      marijuana

      Cannabis Science (CBIS)
      469%

      The company specializes in the development of cannabinoid-based medications and recently announced a collaborative research agreement with Dana Farber/Harvard Cancer Center. Their initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

      From October 3 to October 19 CBIS jumped from $0.0169 to as high as $0.077. After pulling in during December, the stock kicked off the new year with a big bull run all the way to highs of $0.0961 for the year so far.

      cannabis

      Hemp Inc. (HEMP)
      103%

      One of the most vocal companies on Hemp production in the US, Hemp Inc. They’ve continued to push for a ubiquitous acceptance for all uses of the hemp plant for years now and have targeted North Carolina to grow over 3,000 acres of hemp.

      “We are proud to collaborate with other American industrial hemp farmers as we now become part of the modern industrial hemp farming movement. This is a turning point for America and it’s a turning point for Hemp, Inc. Hemp, Inc. has the infrastructure in place to process millions of pounds of hemp fibers and stalks a year, on a commercial level. Our 70,000 square foot industrial hemp processing facility, on over 9 acres in Spring Hope, North Carolina, is the only one of this magnitude in North America. The industrial hemp crop is part of history in the making and it is something that will prove to be lucrative not only for the farmers in North Carolina but for Hemp, Inc. as well,” said CEO Bruce Perlowin in a recent PR.

      HEMP saw a bump in volume early in October, the stock ran from $0.0276 to $0.056 before consolidating in late November/December, and has once again begun to aggressively climb back from that price channel.

      hemp

      Cannabis Sativa, Inc. (CBDS)
      195%

      With multiple subsidiaries, this company has products ranging from hemp oils & capsules to cannabidiol infused bottled water and even its own patented cannabis plan named Ecuadorian Sativa (Patent PP27,475). Back in late September the stock was trading around $2.80 per share before it jumped up to highs of $8.25. After consolidating for weeks leading up to the new year, CBDS has once again followed suit of many marijuana stocks having now climbed back above $8.

      CBD

      OH CANADA!

      This leads us to our “neighbors up north” because we haven’t just seen a boom from US marijuana stocks alone. The trend has echoed into Canada with some of the most anticipated IPOs so far this year

      Emblem Corp. (TSXVENTURE:EMC)(OTCQB:EMMBF)
      55%

      Emblem Corp, a Licensed Cultivator out of Paris Ontario is one of the most watched and anticipated offerings that has come out of Canada in the last few months. Beyond the fact that they are already growing cannabis and revenue producing investors have taken note of one of their founders and current President, a gentleman by the name of John Stewart.

      No, not John Stewart from the Daily Show even though that would be awesome, John Stewart former CEO of Purdue Pharma one of the largest private biotech companies in the world and creators of OxyContin. We see the potential long term to create a cultivator/Biotech hybrid in which case Emblem could be the Next GW Pharma of Canada.

      Marijuana IPO

      InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) (CNSX: IN)
      326%

      This company has been following the same pattern as many of the other cannabis biotechs but also comes with what looks to be a stock promotion behind it. The company recently appointed Jeff Charpentier, CPA, CA as InMed’s Chief Financial Officer & Corporate Secretary as well as Martin Bott to its Board of Directors; Bott has worked at Eli Lilly & Company since 1988 and held a variety of roles in the U.S., Switzerland, Germany, and the UK.

      InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. IMLFF saw a rise in price early in October (shocker right?), a period of consolidation leading up to the new year, and since that ball dropped, the stock has been on the run moving from $0.10 in October to highs of $0.4261 just a few days ago.

      Marijuana Stocks

      Aurora Cannabis Inc. (TSXV: ACB) (OTCQB: ACBFF)
      179%

      The company’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada.

      They just announced that the company has officially surpassed 12,000 registered patients within the first 12 months of product sales in Canada. They also announced that they had signed a Joint Venture Research Agreement with Radient Technologies Inc. (“RTI”). The first phase of this venture will include screening experiments of extraction conditions, while phase two includes larger scale experiments related to extraction throughput and optimal extraction conditions. Aurora’s scientists and the RTI team will commence tests January 16, 2017, and the first phase is expected to be completed within approximately six weeks, so something to keep an eye on here in our opinion.

      Likewise with the other stocks, the market activity has followed suit even though Aurora has differed by not breaking a new high this year as compared to the high it made in November. But the new uptrend on the chart could be a key indicator for future potential. Since October (at $1.06), shares of ACBFF has seen two and possibly three clear runs; One that saw highs of $1.89 before consolidating, another that saw highs of $2.96 before consolidating, and possibly a new uptrend forming now in January.

      Buy marijuana stocks

      These are just a few marijuana stocks that have demonstrated a near identical move in the market both leading into the election and leading up to the inauguration. We’ve said it before and most likely will say it again: Marijuana Stocks can very much be event driven so something to keep in the back of your head as we watch 2017 unfold. As investors become more informed on the industry itself, we’ll keep our had on the pulse to find the real story behind some of the biggest marijuana stock moves in the market today.

       

       

       

       

       


       

      Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. MAPH owns 2 million common restricted shares of mCig Inc. MAPH owns 10 million common restricted shares of Hemp Inc. An affiliate of MAPH owns 70,850 common restricted shares of Emblem Corp. We may buy or sell additional shares of any stocks mentioned, in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information

        7 3278

        We’ve all come here for one reason: Getting Information on Stocks. With most marijuana stocks being considered penny stocks, there are many things that need to be taken into account because yes, they do have higher risk than something like Microsoft or Apple…at least during the early stages of development.

        A lot of the risk comes from volatility in markets. At the drop of a hat a penny stock can explode 20, 50, 100, or even 300% within the matter of weeks or even days. The important part to pay attention to during times of increased volatility is the chart. Historic levels of support and resistance can shed some light on where there are strong points on the chart that show where a price could hold up…especially during times of a pull-back. The main point, as with any stock, is not to let emotion dictate the pace and think logically.

        During times when you get a massive short squeeze and market makers basically need to give up and cover, the second day following a major squeeze needs to be followed closely. Unless there is another monster day of bullish momentum, there’s a good chance that short traders will short even heavier to attempt to make money back after losing “yesterday”. This could trigger some very volatile days to follow and many times, periods of pull-back. The major reason for the pull-back after such a big day has more to do with where the real “retail market” is.

        Obviously a stock can’t go up every day and needs to consolidate but after such a big day on the day of a short squeeze, the market needs to find where the true retail channel is. The point is to stay calm, don’t let emotions dictate the pace. After you see such a big short squeeze, a healthy market will need to find its real base. Keep in mind that most of the time there is a short squeeze, there’s typically more buying coming from short traders and not necessarily retail buying directly. It’s normal to see a pull-back so it’s best to remain calm and pay attention to the historical levels of support and resistance.

        For example if a stock is trading around $2.50-$3.00 consistently and shows clear resistance levels around $3, there’s a good chance that a short is beginning to build in that area. Now say a short squeeze triggers, and that stock has a move above $4; that big move doesn’t necessarily mean that the market is at $4, it could just mean that there wasn’t enough resistance to hold back the price during the time that short sellers needed to buy back shares to cover their short position. Keep in mind that shorting deals with borrowing shares and not borrowing price. What we mean is that if you short a stock, you essentially are borrowing a number of shares of stock and when you need to cover your short, you need to pay back those shares.

        If you were short 100 shares at $2 and now the price is at $4 when you have to cover your short position, you would have been forced to pay double the price in order to pay back your position. This is why we say that a short squeeze doesn’t necessarily represent the true retail market. Again, there can be a lot of volatility following a short squeeze that includes panic selling and heavier shorting so it’s important to stay calm and pay close attention to the trend, sometimes cost averaging at lower prices, or even holding strong as another short squeeze could trigger. All things considered, the final decision is up to you but you should take into account these other factors especially when there is a giant spike in price and volume. A healthy market will not go up every day and taking advantage of the volatility can be where a lot of money could be made.

        Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

        We are your #1 source for all things Marijuana Stocks, Subscribe Below!

        Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
        Ad Placements